Recruitment challenges in rare neurological clinical studies can cause delays to study start-up and hinder the advancement of treatments. This webinar explores the specific hurdles faced in recruiting participants for such studies and offers effective strategies to overcome them.
By understanding the intricacies of rare neurological disorders and the unique circumstances surrounding their study recruitment, researchers can implement targeted approaches to reduce site start-up time and optimize recruitment strategies.
Drawing from case studies and expert experiences, this webinar provides practical insights and best practices to accelerate the recruitment process, ultimately facilitating the development of treatments for these challenging conditions.
Register for this webinar today to learn how to overcome recruitment challenges for rare neurological clinical studies and accelerate the development of critical treatments.
Speakers
Dr. Susan McCune, VP Pediatrics and Clinical Pharmacology, PPD clinical research business of Thermo Fisher Scientific
Dr. McCune is the Vice President for Pediatrics & Clinical Pharmacology in the Medical Science and Strategy Group and part of the Rare Diseases and Pediatrics Center of Excellence. She has more than 35 years of clinical care (board-certified in pediatrics and neonatology), research and regulatory experience.
With 18 years at the FDA, her depth of experience consists of regulatory consulting for all phases of pediatric trials, including the review of study protocols and analysis of data submitted to the FDA.
Message Presenter
Dr. Meagan Spychala, DrPH, RAC, Executive Director, Project Delivery, PPD clinical research business of Thermo Fisher Scientific
Dr. Spychala is an Executive Director of Project Management at PPD, part of Thermo Fisher Scientific, with more than 20 years of experience in the clinical research industry. Her depth of experience overseeing the operations of clinical trials has focused on rare disease clinical trials and trials utilizing gene therapies and cellular therapies.
Dr. Spychala is on the Steering Committee of the Rare Disease and Pediatric Center of Excellence and the Chair of PPD’s Gene Therapy Operational Center of Excellence, ensuring that project teams successfully support the patient, site and sponsor in rare disease and gene therapy research. Dr. Spychala holds a Bachelor’s degree in Mathematics from Washington and Lee University and an MS and DrPH in Biostatistics from the University of North Carolina at Chapel Hill.
Message Presenter
Patti Shugarts, ED, Rare Disease & Neurology, PPD clinical research business of Thermo Fisher Scientific
With over 25 years of clinical research experience, Ms. Shugarts has extensive expertise in multiple rare disease indications, including Prader-Willi Syndrome and various rare neuromuscular and neurodegenerative diseases. She is highly skilled in genetic and gene therapies, particularly within pediatric populations, and has managed both first-in-human and pivotal trials.
As a passionate advocate for rare disease clinical trials, Patti is dedicated to reducing the burden on patients and caregivers. She is an active member of the Rare Disease and Pediatric Center of Excellence and has worked with various patient advocacy groups. Patti has experience in leading cross-functional teams that have consistently delivered excellence in rare disease programs for clients and patients alike.
Message Presenter
Tanya Colhoun, VP, Neuroscience & Rare Disease, PPD clinical research business of Thermo Fisher Scientific
With three decades of clinical research experience, Ms. Colhoun has developed extensive expertise across multiple rare disease indications, including rare neuromuscular and neurodegenerative diseases, as well as rare hematological and respiratory diseases.
She possesses significant experience in genetic and gene therapies, particularly within pediatric populations, and has successfully managed first-in-human and pivotal trials. As the Chair of the Gene Therapy Operational Center of Excellence (CoE) and the Operational Leader for the Rare Disease & Pediatric CoE, Tanya is deeply passionate about reducing the burden on patients and caregivers.
Her proven ability to lead cross-functional teams has consistently resulted in the delivery of exceptional rare disease programs for clients and patients alike.
Message PresenterWho Should Attend?
This webinar will appeal to:
- Biotech and biopharma companies involved in rare disease and neuroscience clinical research
- Clinical Research Investigators and Site Directors
- Patient advocacy and study consortia groups
What You Will Learn
Attendees will learn about:
- The specific challenges associated with recruiting participants for rare neurological clinical studies
- Effective strategies for reducing site start-up time
- Practical insights and best practices from case studies and expert experiences to optimize recruitment
- How to accelerate the advancement of treatments for rare neurological disorders
Xtalks Partner
PPD clinical research business of Thermo Fisher Scientific Inc.
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, enables customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, their capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. Recognized as a global industry leader in accelerating promising medicines from early development through regulatory approval and market access, they serve pharma, biotech, medical device and government organizations with custom-tailored solutions, including full-service partnerships and functional service partnerships. As a strategic partner in clinical development and analytical services, they apply cutting edge technologies, therapeutic expertise and a firm commitment to quality to help customers deliver life-changing therapies.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account